Geron (GERN) Share-based Compensation (2010 - 2026)
Geron's (GERN) quarterly Share-based Compensation came in at $4.9 million in Q1 2026, down 33.81% year-on-year from $7.4 million in Q1 2025, and up 123.62% quarter-over-quarter from -$20.8 million in Q4 2025.
Geron (GERN) Share-based Compensation (2010 - 2026) Analysis & Trends
Geron has disclosed Share-based Compensation across 17 years of filings, most recently posting $4.9 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $4.9 million, down 33.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 108.99% YoY), and the FY2025 annual result was $88000.0, down 34.81% from the prior year.
- Share-based Compensation came in at $4.9 million for Q1 2026 at Geron, up from -$20.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $20.8 million in Q3 2025 to a low of -$20.8 million in Q4 2025.
- The 5-year median for Share-based Compensation is $3.0 million (2023), against an average of $2.6 million.
- Across the five-year window, Share-based Compensation jumped 249.2% in 2023 and tumbled 160100.0% in 2025, its largest moves.
- Geron's Share-based Compensation stood at -$5.5 million in 2022, then jumped by 103.21% to $178000.0 in 2023, then sank by 92.7% to $13000.0 in 2024, then sank by 160100.0% to -$20.8 million in 2025, then soared by 123.62% to $4.9 million in 2026.
- The last three Share-based Compensation figures came in at $4.9 million (Q1 2026), -$20.8 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26.47 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 4.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.91 Mn |
| Mar 31, 2026 | 4.91 Mn |
| Dec 31, 2025 | -20.80 Mn |
| Dec 31, 2025 | -20.80 Mn |
| Sep 30, 2025 | 20.85 Mn |
| Sep 30, 2025 | 20.85 Mn |
| Jun 30, 2025 | -7.38 Mn |
| Jun 30, 2025 | -7.38 Mn |
| Mar 31, 2025 | 7.42 Mn |
| Mar 31, 2025 | 7.42 Mn |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 6.89 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 12.63 Mn |
| Jun 30, 2024 | 12.63 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Dec 31, 2023 | 178,000.00 |
| Dec 31, 2023 | 178,000.00 |